SLCO2B1 and liver cancer: In the liver and pancreas, lower mRNA expression of SLCO2B1 in liver cancer was associated with decreasing differentiation and significantly lower expression of SLCO2B1 was seen in pancreatic cancer compared with normal pancreatic tissue.